Article
Histone deacetylase inhibition, but not a mineralocorticoid receptor antagonist spironolactone, attenuates atypical transcription by an activating mutant MR (MRS 810L ).
Clinical and experimental pharmacology & physiology - 1 Oct 2016
Kang Seol-Hee, Lee Hae-Ahm, Lee Eunjo, Kim Mina, Kim Inkyeom
Abstract excerpt
A mutation in the mineralocorticoid receptor (MRS 810L ) leads to early-onset hypertension, which is markedly exacerbated during pregnancy. The mutation causes progesterone and even the MR antagonist spironolactone to become potent agonists. Thus, it is hard to control hypertension in patients harbouring this mutation. We hypothesized that histone deacetylase inhibition (HDACi), but not the MR antagonist...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
